ARCHIVES

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Plans a Catalog Of Research Tools

April 30, 1999

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992

NCI To Fund 3,232, Research Project Grants In Fiscal 1993

January 15, 1993

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

In Brief: GM Awards Recognize Levine, Levy, Roeder, Tjian; U.S. Science, Tech Medals Awarded

May 14, 1999